(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
Live Chart Being Loaded With Signals
Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage...
Stats | |
---|---|
Šios dienos apimtis | 1.03M |
Vidutinė apimtis | 22 706.00 |
Rinkos kapitalizacija | 40.02M |
EPS | $0 ( 2024-02-23 ) |
Last Dividend | $0.0150 ( 2023-09-07 ) |
Next Dividend | $0 ( N/A ) |
P/E | 27.33 |
ATR14 | $0 (0.00%) |
Cryosite Ltd Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Cryosite Ltd Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $11.94M |
Bruto pelnas: | $6.48M (54.28 %) |
EPS: | $0.0289 |
FY | 2023 |
Pajamos: | $11.94M |
Bruto pelnas: | $6.48M (54.28 %) |
EPS: | $0.0289 |
FY | 2022 |
Pajamos: | $11.76M |
Bruto pelnas: | $6.27M (53.36 %) |
EPS: | $0.0279 |
FY | 2021 |
Pajamos: | $10.02M |
Bruto pelnas: | $5.89M (58.80 %) |
EPS: | $0.0139 |
Financial Reports:
No articles found.
Cryosite Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.0100 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0.0150 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.00500 | 2012-03-16 |
Last Dividend | $0.0150 | 2023-09-07 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 13 | -- |
Total Paid Out | $0.0900 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.12 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.33 | |
Div. Directional Score | 8.29 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
QVE.AX | Ex Dividend Knight | 2023-08-15 | Quarterly | 0 | 0.00% | |
BFG.AX | Ex Dividend Junior | 2023-08-30 | Semi-Annually | 0 | 0.00% | |
JLG.AX | Ex Dividend Junior | 2023-09-01 | Annually | 0 | 0.00% | |
SNC.AX | Ex Dividend Knight | 2023-05-16 | Semi-Annually | 0 | 0.00% | |
CKF.AX | Ex Dividend Knight | 2023-07-10 | Semi-Annually | 0 | 0.00% | |
MPL.AX | Ex Dividend Knight | 2023-09-13 | Semi-Annually | 0 | 0.00% | |
VG1.AX | No Dividend Player | 2023-08-23 | Sporadic | 0 | 0.00% | |
DTL.AX | Ex Dividend Knight | 2023-09-14 | Semi-Annually | 0 | 0.00% | |
ORG.AX | Ex Dividend Knight | 2023-09-05 | Semi-Annually | 0 | 0.00% | |
AGL.AX | Ex Dividend Knight | 2023-08-23 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.125 | 1.500 | 7.50 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0711 | 1.200 | 7.63 | 9.16 | [0 - 0.3] |
returnOnEquityTTM | 0.555 | 1.500 | 4.94 | 7.41 | [0.1 - 1] |
payoutRatioTTM | 0.464 | -1.000 | 5.36 | -5.36 | [0 - 1] |
currentRatioTTM | 2.03 | 0.800 | 4.85 | 3.88 | [1 - 3] |
quickRatioTTM | 1.942 | 0.800 | 3.28 | 2.63 | [0.8 - 2.5] |
cashRatioTTM | 1.458 | 1.500 | 3.01 | 4.51 | [0.2 - 2] |
debtRatioTTM | 0.114 | -1.500 | 8.10 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 15.39 | 1.000 | 5.41 | 5.41 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0493 | 2.00 | 9.98 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0405 | 2.00 | 9.98 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.873 | -1.500 | 6.51 | -9.76 | [0 - 2.5] |
grossProfitMarginTTM | 0.550 | 1.000 | 4.17 | 4.17 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.138 | 1.000 | 9.23 | 9.23 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.952 | 1.000 | 5.82 | 5.82 | [0.2 - 2] |
assetTurnoverTTM | 0.569 | 0.800 | 9.54 | 7.63 | [0.5 - 2] |
Total Score | 11.25 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 25.39 | 1.000 | 7.54 | 0 | [1 - 100] |
returnOnEquityTTM | 0.555 | 2.50 | 6.75 | 7.41 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0405 | 2.00 | 9.99 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 7.93 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0493 | 2.00 | 9.98 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.464 | 1.500 | 5.36 | -5.36 | [0 - 1] |
pegRatioTTM | -0.508 | 1.500 | -6.72 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.191 | 1.000 | 7.73 | 0 | [0.1 - 0.5] |
Total Score | 5.33 |
Cryosite Ltd
Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns management, comparator sourcing, import, export, validated transport, and biological storage solutions to the clinical trials, and research and pharmaceutical industry. The Cord Blood and Tissues Storage segment offers long term storage solutions for cord blood and tissue samples. It serves research, medical, pharmaceutical, veterinary, and biotechnology industries. The company was incorporated in 1999 and is based in South Granville, Australia.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.